Webvent

SCRS Resource Guide Network

Sites, Sponsors, CROs: Discover the solutions your clinical research teams need with SCRS.

Bioclinica

Leader in Clinical Trial Management Solutions

Bioclinica
Header

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies.

Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory.

Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions.

Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a post-approval research division.
 

Videos 

News: Bioclinica blogs 
  • CRO Oversight Is Not Optional: In-House Technology Solutions Can Help August 8, 2017 10:25am

    Ensuring regulatory compliance is quickly becoming a primary reason to consider implementing an in-house, risk-based management/clinical trial quality management system. When sponsors outsource to a CRO, I've found that they often feel as if they are absolved of knowing exactly what is happening, ignoring the need for documented, risk-based oversight processes and procedures. However, oversight IS the sponsor's responsibility, especially given the newly revised ICH (E6 R2) guidelines, in which i...
    View this post

  • Fixing delays in study site activation: 3-Fold Solution August 4, 2017 3:04pm

    What's behind slow site activation? Sean Stanton of Bioclinica Research provides meaningful insights on study site activation in his latest article, 'Improving Site Activation: Three-Fold Solution' published in ICT's August 2017 issue. Having spent the last 25 years of his career focused on creating successful, high-performing research sites, Sean gives a candid look at site activation —   a rarely explored activity critical to laying the foundation for a successful study. To date, he's le...
    View this post

  • Cardiovascular Imaging: Not Just for Cardiovascular Trials August 3, 2017 11:18am

    Cardiovascular disease is the leading cause of death globally with approximately 17.3 million deaths annually. Underlying heart disease are numerous conditions such as atherosclerosis, myocardial infarction, ischemic stroke, heart failure, arrhythmias and heart valve issues. While cardiovascular imaging (CVI) plays a key role in the assessment, diagnosis and treatment of many of these conditions it is also an important tool for collecting safety and efficacy endpoint data in many cardiovascular...
    View this post

  • Patient Engagement in Alzheimer's and Mild Cognitive Impairment Clinical Trials August 2, 2017 11:54am

    Considering the large number of individuals affected by Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), you might expect fast enrollment into clinical trials. The reality is quite different. Sponsors of clinical trials face several obstacles: 1) Patients are underdiagnosed. 2) Patients have a limited knowledge of clinical trials and some misconceptions. 3) AD/MCI clinical trials are complex, prohibiting participation. The fastest and easiest solution is to educate people online. Ho...
    View this post

  • Upcoming Webinar: Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned July 21, 2017 11:31am

    Join us for our upcoming webinar on July 25th during which Sukrit Singh and Dr. Ayesha Hussain, both pharmacovigilance experts who are also Associate Directors of CRM at Bioclinica, Inc., will present and discuss case studies illustrating how market authorization holders and CROs are becoming partners of choice in the ever-changing world of pharmacovigilance outsourcing. The need to comply with regulatory requirements is increasing with the demand for new therapies across the pharmaceutical ind...
    View this post

  • Speeding Up Site Activation Is as Easy as 1-2-3 July 11, 2017 7:55am

    Nobody wants a delay in site activation for a clinical trial. Every delay increases study budgets and reduces the time for market exclusivity. A delay means patients aren't getting needed drugs. Yet delays happen – consistently. So what is the secret to swift site activation? What is the "special sauce" to speed up the process and get studies started on time? Actually, there is no secret. No mystery. No complicated formula. The fact is, speeding up site activation is as easy as 1-2-3. 1. Pra...
    View this post

Information

  • Bioclinica

    United States
    Map It »
    www.bioclinica.com
  • Videos1
  • News6
  • Last UpdatedJune 30, 2017 9:21am EDT

Connect

Contacts